Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001493152-24-034901
Filing Date
2024-09-04
Accepted
2024-09-03 21:52:57
Documents
60
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-qa.htm   iXBRL 10-Q/A 762715
2 ex31-1.htm EX-31.1 11590
3 ex31-2.htm EX-31.2 11575
4 ex32-1.htm EX-32.1 6248
5 ex32-2.htm EX-32.2 6263
  Complete submission text file 0001493152-24-034901.txt   4801676

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE shph-20240331.xsd EX-101.SCH 34360
7 XBRL CALCULATION FILE shph-20240331_cal.xml EX-101.CAL 50309
8 XBRL DEFINITION FILE shph-20240331_def.xml EX-101.DEF 200408
9 XBRL LABEL FILE shph-20240331_lab.xml EX-101.LAB 318060
10 XBRL PRESENTATION FILE shph-20240331_pre.xml EX-101.PRE 268612
62 EXTRACTED XBRL INSTANCE DOCUMENT form10-qa_htm.xml XML 659295
Mailing Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879
Business Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879 (240) 403-4212
Shuttle Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001757499 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-41488 | Film No.: 241275759
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)